Circular.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
167911 Proof 4 Thursday, September 15, 2016 02:46 THIS DOCUMENT AND THE ACCOMPANYING DOCUMENTS ARE IMPORTANT AND REQUIRE LR13.3.1(4) YOUR IMMEDIATE ATTENTION. If you are in any doubt about the Acquisition, the contents of this document, or as to the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank, solicitor, accountant, fund manager or other appropriate independent financial adviser authorised under the Financial Services and Markets Act 2000 (“FSMA”) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent professional adviser in the relevant jurisdiction. If you sell, have sold or otherwise transferred all of your Informa Shares you should send this document and the LR13.3.1(6) accompanying documents, together with the accompanying Form of Proxy, as soon as possible to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for delivery to the purchaser or the transferee. However, the distribution of this document, any accompanying documents and/or the Form of Proxy into certain jurisdictions other than the United Kingdom may be restricted by law. Therefore, persons into whose possession this document and any accompanying documents come should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. If you have sold only part of your holding of your Informa Shares you should retain these documents. INFORMA PLC LR13.4.1(2) Annex 1, 5.1.1 (Incorporated under the Companies Act of 2006 and registered in England and Wales with Registered No. 08860726) PROPOSED ACQUISITION OF PENTON BUSINESS MEDIA HOLDINGS, INC. Circular to Informa Shareholders and Notice of Informa General Meeting Your attention is drawn to the letter from the Chairman of Informa PLC (“Informa”) which is set out on pages 13 to 28 of this document and which contains the recommendation from the Informa Board that you vote in favour of the Resolution to be proposed at the General Meeting referred to below. Please read the whole of this document and, in particular, the risk factors set out in Part II (Risk Factors). Notice of the General Meeting to be held at The Conrad London St James, 22-28 Broadway, London, SW1H 0BH at 10.30 a.m. on 10 October 2016 is set out at the end of this document. A Form of Proxy for use in connection with the General Meeting is enclosed with this document. Whether or not you intend to be present at the General Meeting, you are requested to complete and sign the Form of Proxy in accordance with the instructions printed on it so as to be received by the Registrars, Computershare Investor Services PLC, at The Pavilions, Bridgwater Road, Bristol BS99 6ZY, as soon as possible and, in any event, no later than 10.30 a.m. on 6 October 2016 (or, in the case of an adjournment, not later than 48 hours (excluding non-business days) before the time fixed for the holding of the adjourned meeting). If you hold Informa Shares in CREST, you may appoint a proxy by completing and transmitting a CREST Proxy Instruction to the Registrars, Computershare Investor Services PLC (CREST participant ID 3RA50). Alternatively, you may give proxy instructions by logging on to www.investorcentre.co.uk/eproxy. To appoint a proxy electronically you will be asked to provide your Control Number, Shareholder Reference Number and PIN, which are detailed on your proxy form. Proxies sent electronically must be sent as soon as possible and, in any event, so as to be received by not later than 10.30 a.m. on 6 October 2016 (or, in the case of an adjournment, not later than 48 hours (excluding non-business days) before the time fixed for the holding of the adjourned meeting). The completion and return of a Form of Proxy (or the electronic appointment of a proxy) will not preclude you from attending and voting in person at the General Meeting or any adjournment thereof, if you wish to do so and are so entitled. This document is a circular relating to the Acquisition which has been prepared in accordance with the Listing Rules. This document has been approved by the FCA. This document does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security. The information provided in this document is provided solely in compliance with the Listing Rules for the purpose of enabling Informa Shareholders to consider the Resolution. A prospectus, prepared in accordance with the Prospectus Rules of the FCA made under section 73A of the FSMA, has been approved by the FCA in accordance with section 87A of the FSMA and has been made available to the public in accordance with Rule 3.2.1 of the 167911 Proof 4 Thursday, September 15, 2016 02:46 Prospectus Rules. Any investment decision relating to the Rights Issue should be based upon consideration of the Prospectus, which Qualifying Informa Shareholders (other than, subject to certain exemptions, Qualifying Informa Shareholders with a registered address, or resident or located, in the United States or any of the Restricted Jurisdictions) should read in full prior to making any such investment decision. This document does not constitute a prospectus or a prospectus equivalent document. Nothing in this document should be interpreted as an offer of securities or a term or condition of the Rights Issue. Investors should read the Prospectus for information about the Rights Issue before deciding whether or not to take any investment decision in relation to the Nil Paid Rights, the Fully Paid Rights or the Rights Issue Shares referred to in this document. Investors should not subscribe for or acquire any Nil Paid Rights, Fully Paid Rights or Rights Issue Shares except on the basis of the information, and the terms and conditions of the Rights Issue, contained in the Prospectus. This document cannot be relied on for any investment contract or decision. Each of Morgan Stanley & Co. International plc (“Morgan Stanley”) and N.M. Rothschild & Sons (“Rothschild”), which are authorised by the PRA and regulated by the FCA and the PRA in the United Kingdom, and Centerview Partners UK LLP (“Centerview Partners”), which is authorised and regulated by the FCA in the United Kingdom, is acting as joint financial adviser exclusively to Informa and for no one else in connection with the Acquisition and/or the Rights Issue. In connection with such matters, neither Morgan Stanley, Rothschild, Centerview Partners nor any of their respective affiliates nor any of their or their affiliates’ respective directors, officers, employees and agents will regard any other person (whether or not a recipient of this document) as their respective clients, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in relation to the Acquisition and/or the Rights Issue, the contents of this document or any other matter referred to herein. Morgan Stanley, Rothschild or Centerview Partners assume no responsibility for the accuracy, completeness or verification of this document and accordingly disclaim, to the fullest extent permitted by applicable law, any and all liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this document or any such statement. No representation or warranty, express or implied, is made by Morgan Stanley, Rothschild, Centerview Partners nor any of their respective affiliates, directors, officers, employees and advisers as to the accuracy, completeness or verification of the contents of this document, and nothing contained in this document is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. Barclays Bank PLC, acting through its Investment Bank (“Barclays”), which is authorised by the PRA and regulated by the PRA and the FCA in the United Kingdom, is acting as sponsor, joint financial adviser, joint global coordinator and joint bookrunner exclusively for Informa and no one else in connection with the Acquisition, the Rights Issue and other matters referred to in this document and will not regard any other person (whether or not a recipient of this document) as a client of Barclays in relation to the Acquisition and the Rights Issue and is not, and will not be, responsible to anyone other than Informa for providing the protections afforded to Barclays’ clients or for giving advice in relation to the Acquisition, the Rights Issue or any other matter referred to in this document. Apart from the responsibilities and liabilities, if any, which may be imposed on Barclays by FSMA or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Barclays nor any of its respective subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Barclays for the contents of this document, including its accuracy, correctness or for any other statement made or purported to be made by it, or on its behalf in connection with Informa or the Acquisition, the Rights Issue and other matters referred to in this document.